What is Skin Analytics?
Skin Analytics is at the forefront of utilizing artificial intelligence as a Medical Device (AIaMD) through its DERM platform. The company's core mission is to democratize access to dermatologist-quality skin cancer assessments, thereby reducing the substantial financial burden that skin cancer places on healthcare systems worldwide. By enhancing diagnostic capabilities and streamlining patient pathways, Skin Analytics is poised to transform early detection and treatment of skin malignancies.
How much funding has Skin Analytics raised?
Skin Analytics has raised a total of $26.5M across 4 funding rounds:
Grant
$100K
Corporate Investment
$1.2M
Series A
$5.2M
Series B
$19.9M
Grant (2014): $100K with participation from Founder.org
Corporate Investment (2018): $1.2M led by Bristol Private Equity Club
Series A (2020): $5.2M supported by Mustard Seed Venture INC, Nesta Holding Co, and Hoxton Ventures
Series B (2025): $19.9M featuring Intrepid Partners
Key Investors in Skin Analytics
Intrepid Partners
Intrepid Partners specializes in project management and business consultancy services, primarily for the lease and loan industries. Their involvement suggests a strategic interest in the operational and financial scaling of Skin Analytics.
Hoxton Ventures
Hoxton Ventures is an early-stage venture capital firm focused on European technology startups with global scaling potential. Their investment indicates confidence in Skin Analytics' disruptive technology and market opportunity.
Bristol Private Equity Club
Bristol Private Equity Club connects high-net-worth individuals with early-stage businesses seeking capital. Their participation highlights support for local innovation and early-stage ventures within the UK.
What's next for Skin Analytics?
The recent major strategic investment signals a pivotal growth phase for Skin Analytics. This capital infusion is expected to accelerate the company's expansion, further develop its AIaMD capabilities, and broaden its market reach. The company's focus on sustainable health system solutions suggests a strategic push towards integrating its technology into national healthcare infrastructures, potentially leading to wider adoption and improved public health outcomes in the fight against skin cancer.
See full Skin Analytics company page
